Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michael Huband

9PUBLICATIONS

18CO-AUTHORS

Medical infection agents (incl. prions)Medical mycologyMedical bacteriologyMolecular medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 24, 2025

Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in <i>Streptococcus pneumoniae</i> clinical isolates from the United States according to CLSI guidelines (2019-2021).

Rodrigo E Mendes, Jessica V Pierce, Kelly Wright

|Feb 05, 2025

Characterization of sulopenem antimicrobial activity using <i>in vitro</i> time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolates.

Joshua M Maher, Michael D Huband, Jill M Lindley

|Jan 11, 2024

<i>In vitro</i> activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022).

Michael Pfaller, Michael Huband, Paul A Bien

|Dec 14, 2023

Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests.

Sarah M McLeod, Nicole M Carter, Michael D Huband

|Jul 03, 2023

Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination.

Michael D Huband, Kelley A Fedler, Helio S Sader

|Mar 22, 2023

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.

Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota

Pageof 2

Frequent Collaborators

6 joint publications

Mariana Castanheira

2 joint publications

Helio S Sader

2 joint publications

Cecilia G Carvalhaes

2 joint publications

Rodrigo M Mendes

1 joint publications

Jennifer M Streit

1 joint publications

Dee Shortridge

1 joint publications

Sujata M Bhavnani

1 joint publications

Michael Trang

1 joint publications

Brian D VanScoy

1 joint publications

Christopher M Rubino

Frequent Collaborators

6 joint publications

Mariana Castanheira

2 joint publications

Helio S Sader

2 joint publications

Cecilia G Carvalhaes

2 joint publications

Rodrigo M Mendes

Top Related Videos

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry

Published on : May 24, 2024

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces <em>In Vitro</em>

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces <em>In Vitro</em>

Published on : Apr 21, 2023

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on : Mar 17, 2023

See more related videos

Top Related Videos

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry

Published on : May 24, 2024

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces <em>In Vitro</em>

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces <em>In Vitro</em>

Published on : Apr 21, 2023

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on : Mar 17, 2023

See more related videos